missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. MLH1 Antibody (rMLH1/8630), Novus Biologicals™
  7. 18686574

MLH1 Antibody (rMLH1/8630), Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-23771-100ug

 View more versions of this product

Product Code. 18686574

  • 462.00€ / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

MLH1 Monoclonal antibody specifically detects MLH1 in Human samples. It is validated for Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

MLH1
Monoclonal
0.2 mg/mL
Immunohistochemistry-Paraffin : 1-2 μg/mL
COCA2FCC2, DNA mismatch repair protein Mlh1, hMLH1, HNPCC, HNPCC2MGC5172, mutL (E. coli) homolog 1 (colon cancer, nonpolyposis type 2), mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli), MutL protein homolog 1
Recombinant full-length human MLH1 protein
100 μg
Apoptosis, Breast Cancer, Cancer, Cell Cycle and Replication, Checkpoint signaling, DNA Double Strand Break Repair, DNA Repair, Mismatch Repair, Tumor Suppressors
4292
Store at 4°C.
IgG1 κ
Immunohistochemistry (Paraffin)
rMLH1/8630
Unconjugated
10 mM PBS with 0.05% BSA
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.